The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review

[1] Ager RR(2015)Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of alzheimer's disease and neuronal loss Hippocampus 25 813-826

[2] Al-Chalabi A(2016)Amyotrophic lateral sclerosis: moving towards a new classification system Lancet Neurol 15 1182-1194

[3] Hardiman O(2017)Induced pluripotent stem cell-derived neural stem cell transplantations reduced behavioral deficits and ameliorated neuropathological changes in YAC128 mouse model of Huntington's disease Front Neurosci 10 628-33

[4] Kiernan MC(2019)Roles of mesenchymal stem cells in tissue regeneration and immunomodulation Biomol Ther (Seoul). 27 25-932

[5] Chiò A(2020)Umbilical cord mesenchymal stem cells in amyotrophic lateral sclerosis: an original study Stem Cell Rev Rep 16 922-665

[6] Rix-Brooks B(2013)The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington’s disease J Neurol Neurosurg Psychiatry 84 657-e2305

[7] van den Berg LH(2021)Synaptic dysfunction in multiple sclerosis: a red thread from inflammation to network disconnection Int J Mol Sci 22 9753-172

[8] Al-Gharaibeh A(2019)NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results Neurology 93 e2294-364

[9] Culver R(2020)Mesenchymal stem cells in Parkinson's disease: Motor and nonmotor symptoms in the early posttransplant period Surg Neurol Int 11 380-174

[10] Stewart AN(2020)Differential timing and coordination of neurogenesis and astrogenesis in developing mouse hippocampal subregions Brain Sci 10 909-36

[1] Ager RR(2015)Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of alzheimer's disease and neuronal loss Hippocampus 25 813-826

[2] Al-Chalabi A(2016)Amyotrophic lateral sclerosis: moving towards a new classification system Lancet Neurol 15 1182-1194

[3] Hardiman O(2017)Induced pluripotent stem cell-derived neural stem cell transplantations reduced behavioral deficits and ameliorated neuropathological changes in YAC128 mouse model of Huntington's disease Front Neurosci 10 628-33

[4] Kiernan MC(2019)Roles of mesenchymal stem cells in tissue regeneration and immunomodulation Biomol Ther (Seoul). 27 25-932

[5] Chiò A(2020)Umbilical cord mesenchymal stem cells in amyotrophic lateral sclerosis: an original study Stem Cell Rev Rep 16 922-665

[6] Rix-Brooks B(2013)The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington’s disease J Neurol Neurosurg Psychiatry 84 657-e2305

[7] van den Berg LH(2021)Synaptic dysfunction in multiple sclerosis: a red thread from inflammation to network disconnection Int J Mol Sci 22 9753-172

[8] Al-Gharaibeh A(2019)NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results Neurology 93 e2294-364

[9] Culver R(2020)Mesenchymal stem cells in Parkinson's disease: Motor and nonmotor symptoms in the early posttransplant period Surg Neurol Int 11 380-174

[10] Stewart AN(2020)Differential timing and coordination of neurogenesis and astrogenesis in developing mouse hippocampal subregions Brain Sci 10 909-36